Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 00:00 | 23 Apr | 993.25 |
0.30 (0.03%) |
OPEN
998.95 |
HIGH
1006.65 |
LOW
980.30 |
NSE 00:00 | 23 Apr | 993.35 |
0.15 (0.02%) |
OPEN
996.95 |
HIGH
1008.90 |
LOW
980.10 |
OPEN | 998.95 |
PREVIOUS CLOSE | 992.95 |
VOLUME | 108877 |
52-Week high | 1023.10 |
52-Week low | 605.05 |
P/E | 19.52 |
Mkt Cap.(Rs cr) | 58,195 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Nine Monthly Result
Particulars (![]() |
Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 |
Net Sales/Income From Operations | 11654.90 | 9646.16 | 8977.31 | 7948.43 | 7361.12 |
Other Income | 339.17 | 97.40 | 92.07 | 74.29 | 84.73 |
Total Income | 11994.07 | 9743.56 | 9069.38 | 8022.72 | 7445.85 |
Total Expenditure | 8509.18 | 7809.00 | 7323.46 | 5756.30 | 5567.16 |
Operating Profit | 3484.89 | 1934.56 | 1745.92 | 2266.42 | 1878.69 |
Interest | 22.69 | 78.12 | 96.08 | 35.48 | 36.10 |
Gross Profit | 3462.20 | 1856.44 | 1649.84 | 2230.94 | 1842.59 |
Depreciation | 360.56 | 351.63 | 303.70 | 263.28 | 212.79 |
PBT | 3101.64 | 1504.81 | 1346.14 | 1967.66 | 1629.80 |
Tax | 840.04 | 309.69 | 238.05 | 463.18 | 378.49 |
Net Profit/(Loss) | 2256.73 | 1147.70 | 1069.58 | 1504.48 | 1251.31 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 2256.73 | 1147.70 | 1069.58 | 1504.48 | 1251.31 |
Equity Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.52 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 38.51 | 19.59 | 18.25 | 25.68 | 21.38 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices